Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.023 USD | -0.14% | -13.40% | +6.87% |
May. 14 | Aprea Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 02 | Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza as Chief Medical Officer | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- APRE Stock
- Revisions Aprea Therapeutics, Inc.